Comparative efficacy of escitalopram in the treatment of major depressive disorder
Mazen K Ali, Raymond W LamDepartment of Psychiatry, University of British Columbia, and Mood Disorders Centre, University of British Columbia Hospital, Vancouver, CanadaBackground: Escitalopram is an allosteric selective serotonin reuptake inhibitor (SSRI) with some indication of superior efficacy i...
Saved in:
Main Authors: | Mazen K Ali, Raymond W Lam |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2011
|
Subjects: | |
Online Access: | https://doaj.org/article/202c6de51be34c86b4a2ce40c0eec2b4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of generic escitalopram (Lexacure®) in patients with major depressive disorder: a 6-week multicenter, randomized, rater-blinded, escitalopram-comparative, non-inferiority study
by: Jeong JH, et al.
Published: (2015) -
Escitalopram vs duloxetine in acute treatment of major depressive disorder: meta-analysis and systematic review
by: Maneeton B, et al.
Published: (2018) -
The therapeutic potential of escitalopram in the treatment of panic disorder
by: Mark H Townsend, et al.
Published: (2007) -
Desvenlafaxine in the treatment of major depressive disorder
by: Maria Teresa C Lourenco1, et al.
Published: (2009) -
Lower serum brain-derived neurotrophic factor levels are associated with failure to achieve remission in patients with major depression after escitalopram treatment
by: Lee BH, et al.
Published: (2014)